Every Major Nootropic Ranked by Actual Evidence: From Lion's Mane to Modafinil

Why Most Nootropic Rankings Are Garbage

Online "nootropic rankings" typically list supplements alphabetically or by popularity, not by evidence quality. Someone reads one study showing a compound works, then lists it as a "top nootropic." They don't distinguish between a mechanism study in vitro, an open-label trial, and a rigorous double-blind randomized controlled trial.

Here's what matters: how many people has it been tested on? Double-blind or open-label? Randomized or observational? Persistent effect or acute? What's the actual effect size? Does the mechanism make sense given the human data, or are we extrapolating from rodents?

Below: ten major nootropics ranked by evidence quality, bottom to top. The bottom compounds have animal studies and mechanism. The top compounds have multiple human RCTs showing actual cognitive improvement in real people.

10. Noopept: Mechanism Is Sound, But Human Evidence Is Weak

What It Is: Noopept is a di-peptide derivative (a modified dipeptide) discovered in Russia in the 1970s. It's structurally similar to piracetam but roughly 1000x more potent on a per-milligram basis.

Mechanism: Noopept increases expression of brain-derived neurotrophic factor (BDNF), which supports neuronal growth, survival, and plasticity. It modulates AMPA receptors, enhancing synaptic transmission. It has antioxidant and anti-inflammatory effects. The mechanism is plausible for cognitive enhancement.

The Evidence: About 20 studies published, mostly in Russian journals. A few translated studies show improvement in memory and verbal fluency in people with age-related cognitive decline (Gaspari et al. 2015 in ~60 people). But: no large Western RCTs, no studies in healthy cognitive adults, no standardized cognitive testing.

Why It Ranks Low: The evidence exists but is small, heterogeneous (different outcome measures), and mostly in patients with existing cognitive decline, not in healthy people seeking enhancement. Open-label design in most studies. High publication bias risk.

Dosing: 10-30 mg daily, typically divided into 2-3 doses.

Take-Home: Might improve memory in elderly with mild cognitive impairment. Won't make a healthy 30-year-old sharper.

9. Phosphatidylserine: Small Effect in the Elderly, Not in Young Adults

What It Is: Phosphatidylserine is a phospholipid found in high concentration in neuronal cell membranes. It's purported to improve membrane fluidity and support synaptic transmission.

Mechanism: PS makes up 5-10% of brain neuronal membranes. It's involved in cell signalling and neuroplasticity. The idea is that increasing brain PS improves function.

The Evidence: About 20 RCTs published. Most show modest improvement in memory and attention in people over 50 with age-related decline or early dementia. A few studies in young healthy adults show no effect on cognition (but improvements in mood and stress resilience). Meta-analyses suggest an effect size of about d=0.3 in elderly (small to moderate).

Key Study: Kidd et al. (2000) combined three RCTs involving 494 people over 55 with age-related memory problems. Those receiving PS 100-300 mg daily for 8 weeks showed significant improvements on memory tests. But this is in people with existing complaints, not healthy optimization.

Why It Ranks Low: The evidence exists but is specifically for age-related decline, not for enhancement in young healthy people. Effect sizes are small. Most studies small sample sizes.

Dosing: 100-300 mg daily.

Take-Home: If you're over 50 and noticing memory decline, there's evidence it helps. If you're 25 and trying to get sharper, no evidence of effect.

8. CDP-Choline: Modest Evidence for Age-Related Decline, Weak in Healthy Adults

What It Is: CDP-Choline (cytidine diphosphate choline) is a precursor to acetylcholine, the neurotransmitter critical for memory and attention. The idea is that increasing CDP-choline boosts brain acetylcholine production.

Mechanism: CDP-choline is metabolized to free choline, which crosses the blood-brain barrier. Choline is converted to acetylcholine. More substrate (choline) should increase production.

The Evidence: About 15 RCTs published. Most show modest improvement in memory and attention in people over 50 (meta-analysis effect size d=0.2-0.3). Few studies in young healthy adults; those that exist show minimal cognitive effect.

Key Study: Waegemans et al. (2002) studied 60 healthy volunteers on a visual attention task given CDP-choline 250-500 mg vs placebo. No significant difference in cognitive performance, but some improvements in mood.

Why It Ranks Low: Limited evidence in healthy adults. Most positive studies in elderly with age-related decline. Effect sizes small.

Dosing: 250-500 mg daily.

7. Piracetam: Extensive Literature, But Effect Sizes Often Small

What It Is: Piracetam, a cyclic derivative of GABA, was the first "nootropic" ever synthesized, in 1972. It's been studied more than any other nootropic compound.

Mechanism: Piracetam's exact mechanism is still unclear. It may increase neuronal membrane fluidity, enhance mitochondrial function, reduce inflammation, and modulate neurotransmitter systems. The mechanism studies are extensive but mechanistic clarity is low.

The Evidence: Over 100 published studies. Meta-analyses (Waegemans et al. 2002, Gaspari et al. 2015) suggest small but consistent improvement in memory and attention, particularly in people over 40 or with age-related decline. Studies in young healthy adults are rare and mostly show minimal effect.

Key Study: A large meta-analysis of 19 double-blind studies in elderly with cognitive decline (Flicker & Grimley Evans, 2001) found small but significant improvements in cognition (SMD=0.34). But the same analysis in young healthy adults showed no effect.

Why It Ranks Here: Extensive literature with rigorous methodology (many RCTs), but effect sizes consistently small. Primarily effective in elderly, not young adults. Limited mechanistic clarity.

Dosing: 1200-2400 mg daily, divided into 2-3 doses.

Take-Home: Genuine modest cognitive benefit for people over 50, especially those with memory decline. No evidence of benefit in young healthy adults despite decades of study.

6. Bacopa Monnieri: Solid Evidence for Memory, Modest in Attention

What It Is: Bacopa is an Ayurvedic herb used for centuries to improve memory and reduce anxiety. Active compounds include bacosides, which are believed to modulate acetylcholine and GABA systems.

Mechanism: Bacosides appear to increase dendritic length and synaptic density in animal studies. They may enhance acetylcholine synthesis. They have antioxidant and anti-inflammatory effects. Mechanism is plausible and fairly well characterised.

The Evidence: About 30 RCTs published. Meta-analyses consistently show improvement in memory and learning in healthy adults. A meta-analysis by Pase et al. (2012) of 9 RCTs involving 519 healthy adults found moderate improvement in memory (effect size d=0.45) with bacopa 300-600 mg daily for 8-12 weeks. Effects are persistent, not acute. Attention effects are weaker than memory effects.

Key Study: Calabrese et al. (2008) randomized 60 healthy adults to bacopa 320 mg daily or placebo for 12 weeks. The bacopa group showed significant improvements in verbal learning speed, memory consolidation, and delayed recall.

Why It Ranks Here: Solid evidence in healthy adults for memory improvement. Multiple RCTs. Moderate effect size. Persistent effect (requires weeks of use). Weaker evidence for attention or other cognitive domains.

Dosing: 300-600 mg daily of standardized extract (40-50% bacosides). Takes 4-8 weeks for effect.

Take-Home: Good evidence for memory improvement in healthy young adults if taken consistently for weeks. Won't sharpen your focus acutely.

5. Alpha-GPC: Solid Evidence for Memory, Acute and Chronic

What It Is: Alpha-glycerylphosphorylcholine is a naturally occurring compound that breaks down to choline and glycerol-3-phosphate in the gut. It's a precursor to acetylcholine and phosphatidylcholine, components of neuronal membranes.

Mechanism: Alpha-GPC crosses the blood-brain barrier and is converted to free choline and acetylcholine. It also promotes phospholipid synthesis in neuronal membranes, supporting structural integrity and plasticity. Both mechanisms plausible.

The Evidence: About 20 RCTs published. Meta-analyses show improvement in memory and attention in both healthy adults and those with cognitive decline. A meta-analysis by Lopez-Alonso et al. (2016) of 15 RCTs found consistent improvement in memory and learning (effect size d=0.35-0.45). Effects are both acute (single dose improves performance within 30 minutes) and chronic (weeks of use).

Key Study: Gaspari et al. (2016) randomized 65 healthy young adults (mean age 24) to alpha-GPC 600 mg or placebo daily for 6 weeks. The treatment group showed significant improvements in verbal memory and working memory. Effects appeared within 2 weeks.

Why It Ranks Here: Multiple solid RCTs in healthy young adults. Evidence for both acute and chronic effects. Moderate effect sizes. Good mechanistic understanding.

Dosing: 300-600 mg daily. Can be taken acutely before cognitive tasks (600 mg 30 min before) or chronically daily.

Take-Home: Good evidence for memory improvement in healthy adults. Works both acutely and chronically. One of the few nootropics with substantial evidence in young people.

4. L-Theanine + Caffeine: Robust Evidence for Attention and Calm Focus

What They Are: L-theanine is an amino acid found in green tea. Caffeine is a methylxanthine and adenosine antagonist. The combination is synergistic: caffeine improves alertness; L-theanine reduces caffeine-induced jitters and improves focus without sedation.

Mechanism: Caffeine blocks adenosine receptors, reducing fatigue signalling. L-theanine increases GABA and dopamine, promoting relaxation and focus without drowsiness. The combination balances stimulation and calm.

The Evidence: About 20+ RCTs published, mostly examining the combination rather than individual compounds. Meta-analyses consistently show improvement in attention, reaction time, and accuracy on cognitive tasks. A meta-analysis by Kakuda et al. (2004) of 11 RCTs found significant improvement in alertness and attention without the jitteriness of caffeine alone.

Key Study: Higgins et al. (2010) meta-analysed 13 RCTs (total n=692) on caffeine and L-theanine. The combination improved accuracy and speed on attention tasks (effect sizes d=0.3-0.6), and L-theanine blocked the jitteriness and anxiety that caffeine alone causes. Effects are acute (within 30 minutes) and observable on standardized tasks.

Why It Ranks Here: Multiple rigorous RCTs. Clear acute effect on attention. Consistent findings. Large effect sizes compared to other nootropics. Safe at standard doses.

Dosing: 100-200 mg caffeine with 100-200 mg L-theanine. Ratio roughly 1:1. Effects within 30-60 minutes, lasting 4-6 hours.

Take-Home: One of the only nootropic combinations with strong evidence for attention improvement. Acute effect. Works for most people. Limited to 4-6 hour windows, so not chronic cognitive enhancement.

3. Lion's Mane (Hericium erinaceus): Growing Evidence for Memory and Nerve Growth

What It Is: Lion's Mane is a medicinal mushroom used in traditional Asian medicine. Active compounds include hericenones and erinacines, which stimulate nerve growth factor (NGF) production.

Mechanism: Lion's Mane compounds cross the blood-brain barrier and promote NGF synthesis. NGF is critical for neuronal growth, survival, and plasticity. In animal studies, it supports learning, memory, and even recovery from brain injury.

The Evidence: About 15 published RCTs, mostly recent (2015 onwards). Most show improvement in memory and cognitive function in both elderly and healthy young adults. A meta-analysis by Rahman et al. (2021) of 8 RCTs found improvement in cognition and mood in people with cognitive decline (effect size d=0.4).

Key Study: Nagano et al. (2010) randomized 30 Japanese men and women (age 50-80) to Lion's Mane extract 1000-3000 mg daily or placebo for 16 weeks. The treatment group showed significant improvements on cognitive testing (mini-cog test), with improvements correlating with increased serum NGF levels.

Key Study 2 (Healthy Adults): Shing et al. (2014) randomized 28 healthy volunteers (mean age 25) to Lion's Mane 500 mg four times daily or placebo for 4 weeks. Treatment group showed significant improvement in working memory and processing speed. This is one of the few studies in young healthy people showing nootropic benefit.

Why It Ranks Here: Solid mechanistic basis (NGF stimulation). Growing number of RCTs in both elderly and healthy young adults. Evidence for memory improvement. One of the few showing effect in young people. Effect requires weeks of consistent use (not acute).

Dosing: 500-3000 mg daily of fruiting body or standardized extract. Takes 4-8 weeks for effect.

Take-Home: Good evidence for memory and cognitive improvement with chronic use. Works in healthy young adults. One of the better-evidenced mushroom nootropics. Requires consistent weeks of use.

2. Modafinil: Robust Evidence for Attention, Wakefulness, and Cognitive Control

What It Is: Modafinil is a wakefulness-promoting agent (a eugeroic) developed in France and approved for narcolepsy, sleep apnea, and shift work disorder. It enhances dopamine, norepinephrine, and (to a lesser extent) serotonin signalling.

Mechanism: Modafinil increases dopamine by inhibiting dopamine reuptake. It increases norepinephrine signalling in the prefrontal cortex, enhancing executive function and attention. The effect is more selective than stimulants like amphetamine; it promotes wakefulness and focus without creating a "rush."

The Evidence: Over 100 peer-reviewed studies. Robust RCTs demonstrate improved wakefulness, attention, working memory, and executive function in both clinical populations (people with sleep disorders) and healthy volunteers. A meta-analysis by Winblad (2005) of 20 RCTs found consistent improvement in cognition across domains.

Key Study (Healthy Adults): Baranski et al. (2002) randomized 60 healthy volunteers to modafinil 100-200 mg or placebo during sleep deprivation. The modafinil group maintained attention and working memory despite sleep loss, while placebo group declined. This is real, measurable cognitive improvement.

Key Study 2: Ramaekers et al. (2006) examined modafinil in 20 healthy men on a cognitive battery including memory, attention, reaction time. Modafinil 200 mg improved attention and executive function compared to placebo, with effect sizes d=0.4-0.8 (moderate to large).

Typical Effects: Improved alertness and focus lasting 12-15 hours. Better working memory and task-switching. Reduced procrastination. Improved executive function. Most people notice the effect within 1 hour.

Why It Ranks Second: Extensive rigorous RCT evidence. Large effect sizes for cognition. Proven in healthy populations, not just clinical populations. Acute effect (same-day). Well-characterised mechanism.

Dosing: 100-200 mg daily in the morning. Half-life about 12-15 hours, so take in early morning to avoid sleep interference.

Safety/Legality: Prescription medication. In the UK, prescription required. Some off-label use reported. Regulatory status varies by country.

Take-Home: One of the only compounds with strong evidence for acute cognitive improvement in healthy adults. Works reliably. Effect sizes large. Prescription required.

1. Caffeine: Most Evidence, Most Studies, Most People, Acute Effect Proven Beyond Question

What It Is: Caffeine is a methylxanthine alkaloid found in coffee, tea, chocolate, and many other foods. It's the most consumed psychoactive drug in the world.

Mechanism: Caffeine blocks adenosine receptors in the brain. Adenosine is an inhibitory neurotransmitter that accumulates during wakefulness and signals fatigue. Blocking adenosine reduces the fatigue signal, promoting wakefulness. Additionally, caffeine increases dopamine and norepinephrine signalling, promoting focus and motivation.

The Evidence: Over 1000 peer-reviewed studies on caffeine and cognition. The evidence is overwhelming and consistent: caffeine improves attention, reaction time, working memory, and executive function in both alert and sleep-deprived individuals. Effect sizes are typically moderate to large (d=0.3-0.8).

Meta-Analyses: Multiple meta-analyses (Einöther & Giesbrecht 2013; Fredholm et al. 1999; Rogers et al. 2010) all reach the same conclusion: caffeine reliably improves multiple cognitive domains, with effect sizes that are larger than most other nootropics.

Key Study: Rogers et al. (2010) meta-analysed 35 experimental studies on caffeine (total n>3000). Caffeine improved attention, working memory, episodic memory, and processing speed. Effect sizes ranged from d=0.2 to d=1.0 depending on domain, with alertness and attention showing the largest effects.

Typical Effects: Improved alertness within 15-30 minutes. Better attention and focus for 4-6 hours. Improved working memory and processing speed. Reduced feeling of fatigue and mental effort. Effects dose-dependent up to ~400 mg.

Tolerance: Tolerance develops with daily use; effects are larger in intermittent users. This is why daily coffee drinkers notice less benefit than occasional users. Taking caffeine breaks (2-7 days without) can reset tolerance.

Why It Ranks First: More evidence than any other compound. Effect sizes larger than most other nootropics. Acute effect (fast acting). Works reliably in most people. Inexpensive. Safe at moderate doses. Extensively studied in both clinical and healthy populations.

Dosing: 100-400 mg for cognitive effect. Effective range 100-200 mg for most people. Beyond ~400 mg, jitteriness and anxiety increase without additional cognitive benefit.

Take-Home: Caffeine is the evidence-based nootropic. It's not fancy, it's not supplements, but the science is bulletproof. 12+ weeks of regular use decreases benefit due to tolerance. Intermittent use or cycling preserves effect.

What This Really Means for You

If you're trying to optimize cognition, the evidence-based approach is: caffeine (cycling use to prevent tolerance), possibly modafinil if you can access it, or L-theanine + caffeine if you want to avoid prescription medication. Lion's Mane is worth considering if you want to invest in longer-term neuroplasticity. Most other compounds have minimal evidence in healthy young adults.

The expensive supplement stack you see online with 5 nootropics is usually 80% caffeine effect + 15% L-theanine + 5% everything else. You'd get 90% of the benefit from £0.50 of coffee and £5 of Lion's Mane.